Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q3 EBITDA ex-items effecting comparability up by 22 pct

Oct 27 (Reuters) - Xvivo Perfusion AB  XVIVO.ST : 
    * Q3 net sales 31.7 million Swedish crowns ($3.56 million) versus 26.6 million crowns year 
ago 
    * Q3 EBITDA ex-items effecting comparability up by 22 percent to 5.4 million crowns 
 
Source text for Eikon:  ID:nWkrjA1074  
     
Further company coverage:  XVIVO.ST  
 
($1 = 8.9092 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news